BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
17 results:

  • 1. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/gp130 Signaling Pathway.
    Wu X; Cao Y; Xiao H; Feng J; Lin J
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
    Wolf CL; Pruett C; Lighter D; Jorcyk CL
    Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IL-6 Cytokine Family: A Putative Target for Breast cancer Prevention and treatment.
    Felcher CM; Bogni ES; Kordon EC
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163731
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
    Mi F; Gong L
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.
    Meads MB; Fang B; Mathews L; Gemmer J; Nong L; Rosado-Lopez I; Nguyen T; Ring JE; Matsui W; MacLeod AR; Pachter JA; Hazlehurst LA; Koomen JM; Shain KH
    Oncogene; 2016 May; 35(21):2723-34. PubMed ID: 26387544
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
    Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
    BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Negative-pressure wound therapy for musculoskeletal tumor surgery.
    Sakellariou VI; Mavrogenis AF; Papagelopoulos PJ
    Adv Skin Wound Care; 2011 Jan; 24(1):25-30. PubMed ID: 21173588
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
    Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells.
    Lentzsch S; Chatterjee M; Gries M; Bommert K; Gollasch H; Dörken B; Bargou RC
    Leukemia; 2004 Nov; 18(11):1883-90. PubMed ID: 15356648
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma.
    Hideshima T; Chauhan D; Hayashi T; Akiyama M; Mitsiades N; Mitsiades C; Podar K; Munshi NC; Richardson PG; Anderson KC
    Oncogene; 2003 Nov; 22(52):8386-93. PubMed ID: 14627979
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
    Kallen KJ
    Biochim Biophys Acta; 2002 Nov; 1592(3):323-43. PubMed ID: 12421676
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
    Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
    Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells.
    Grant SL; Douglas AM; Goss GA; Begley CG
    Growth Factors; 2001; 19(3):153-62. PubMed ID: 11811789
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Isolation and characterization of the human gp130 promoter. Regulation by STATS.
    O'Brien CA; Manolagas SC
    J Biol Chem; 1997 Jun; 272(23):15003-10. PubMed ID: 9169475
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Allogeneic blood stem cell transplantation in advanced hematologic cancers.
    Przepiorka D; Anderlini P; Ippoliti C; Khouri I; Fietz T; Thall P; Mehra R; Giralt S; Gajewski J; Deisseroth AB; Cleary K; Champlin R; van Besien K; Andersson B; Körbling M
    Bone Marrow Transplant; 1997 Mar; 19(5):455-60. PubMed ID: 9052911
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression and function of members of the cytokine receptor superfamily on breast cancer cells.
    Douglas AM; Goss GA; Sutherland RL; Hilton DJ; Berndt MC; Nicola NA; Begley CG
    Oncogene; 1997 Feb; 14(6):661-9. PubMed ID: 9038373
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The biology of interleukin 11.
    Neben S; Turner K
    Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.